Corvex, Inc. (MOVE) Q2 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Movano Health Q2 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Jake Hogan, Chief Financial Officer Thank you, Mr. Kogan. You may begin. Thanks, operator. Good afternoon, everyone, and thank you for joining us today. Movano Health CEO John Mestre-Tataro will open today's call with prepared remarks about the progress the company made during the second quarter of 2024 and in recent weeks. Our CMO, Tyler Booker, will provide some remarks on the company's upcoming D2C plans, followed again by John, and then I'll provide highlights on the company's quarterly operating results and current financial position. Then we'll open the call for Q&A. John, Jay, and Tyler will be joined by our Chief Technology Officer and Founder, Michael Liebman, Chief Commercial Officer, Michael Soule, and Vice President of Product and Strategy, Stacy Salvi. Movano Health issued a news release this afternoon detailing second quarter 2024 financial results. Before we begin, I'd like to remind everyone that the company will make forward-looking statements during today's call based on current expectations. Whether in prepared remarks or during the Q&A session, these forward-looking statements are subject to inherent risks and uncertainties, and actual results may be materially different from such statements. These risks and uncertainties are detailed in the risk factors section of Movano Health's filings with the Securities and Exchange Commission, specifically in...